Search results
Catching cancer early lowers risk of mortality, but screening is the first step
Stacker via AOL· 1 day agoHowever, the vaccine isn't protective against all types of cervical cancer, so it is essential for...
Cancer Survivors Are Sharing The Weird Symptom That Made Them Go "Hm, Something Isn't Right Here,"...
BuzzFeed via Yahoo News· 6 days ago"If they tell you it might be cancer and have you come back in a couple of weeks for a biopsy, say...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 2 days agoParents need a hand," he said. "If the government helps de-risk that, in pediatric cancers, we'll...
Sponsored: New screening guidelines don’t change need for doctor visits
The Grass Valley Union· 2 days agoIn the past several years, much has changed in regard to preventive screenings and women’s health,...
Free diapers: When qualifying Tennessee families can get them – and how to get help now
Gannett via AOL· 18 hours agoWho qualifies for TennCare? According to TennCare, people who might qualify include: Adults with...
Three Reasons to Retain BD (BDX) Stock in Your Portfolio Now
Zacks via Yahoo Finance· 3 days agoYou can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. DaVita’s shares...
Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC
Clinical Trials Arena via Yahoo Finance· 4 days agoWith the combination administered every six weeks, Arm C...every six weeks suggest a potential...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 3 days agoRemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate RC88 PR Newswire YANTAI, China, June 3, 2024 YANTAI, China, June 3, 2024 /PRNewswire/ -- RemeGen Co., Ltd. ("
Dual Immunotherapy Improves Response Rates in Gynecologic Clear Cell Cancers
MedPage Today· 3 days agoAmong 14 patients who received nivolumab alone...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 4 days ago“As our company is now increasingly focused on our lead asset petosemtamab and plan to initiate phase 3 trials in head and neck cancer later this year, we aim to advance clinical ...
